Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00406848 · ClinicalTrials.gov registry record · Phase 4
A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the Treatment of Depression in Elderly Patients
A Phase 4 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 4
- Development phase
- 370
- Enrollment target
NCT00406848 is a Phase 4 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 370 participants.
The verdict
NCT00406848, a Phase 4 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 370 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the efficacy and safety of duloxetine 60 mg once daily to placebo on depression in elderly patients (greater than or equal to 65 years of age). Patients who do not respond in the first 13 weeks will be eligible for rescue using pre-defined criteria. Patients randomized to duloxetine 60 mg/day meeting the rescue criteria will be increased to 120 mg/day. Patients randomized to the placebo arm meeting the rescue criteria will be assigned to duloxetine 60 mg/day.
Interventions
- DRUG placebo
- DRUG duloxetine hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 370 participants |
| Start Date | 2006-11 |
| Est. Completion | 2009-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00406848
The ClinicalTrials.gov registry entry for NCT00406848 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 370 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00406848 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00406848 about?
NCT00406848 is a clinical study titled "A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the Treatment of Depression in Elderly Patients". The purpose of this study is to compare the efficacy and safety of duloxetine 60 mg once daily to placebo on depression in elderly patients (greater than or equal to 65 years of age). Patients who do not respond in the first 13 weeks will be eligible for rescue using pre-defined criteria. Patients r...
What is the current status of trial NCT00406848?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 370 participants. The study started on 2006-11. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00406848?
The interventions under investigation include: placebo (DRUG), duloxetine hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00406848?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.